{"gene":"HAX1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1997,"finding":"HAX-1 was identified as a novel intracellular protein that directly associates with HS1 (a substrate of Src family tyrosine kinases); the association is mediated by the amino-terminal region of HS1 and the carboxyl-terminal half of HAX-1, confirmed by yeast two-hybrid, co-immunoprecipitation, and confocal colocalization. HAX-1 localizes mainly to mitochondria but also to endoplasmic reticulum and nuclear envelope.","method":"Yeast two-hybrid screening, co-immunoprecipitation, confocal microscopy, deletion mutant analysis","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP and deletion mapping in multiple cell lines, foundational paper","pmids":["9058808"],"is_preprint":false},{"year":2000,"finding":"HAX-1 interacts with the polycystic kidney disease protein PKD2 (but not the closely related PKD2L), and associates with the F-actin-binding protein cortactin, linking PKD2 to the actin cytoskeleton. PKD2 and HAX-1 co-localize in cellular processes and lamellipodia.","method":"Yeast two-hybrid screen, immunofluorescence co-localization","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 3 — yeast two-hybrid with immunofluorescence confirmation, single lab","pmids":["10760273"],"is_preprint":false},{"year":2002,"finding":"HAX-1 can form homodimers in vivo and functions as a potent inhibitor of apoptosis. The KSHV K15 protein interacts with HAX-1 in vitro and in vivo, and HAX-1 co-localizes with K15 in the endoplasmic reticulum and mitochondria.","method":"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, immunofluorescence, apoptosis assays","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and functional apoptosis assays, single lab","pmids":["11752170"],"is_preprint":false},{"year":2002,"finding":"HAX-1 binds the 3' untranslated region of vimentin mRNA as part of protein complexes also containing eEF-1gamma; recombinant HAX-1 protein binds this RNA in vitro with apparent specificity for vimentin's 3'UTR, identifying HAX-1 as an RNA-binding protein potentially involved in mRNA localization or stability.","method":"Yeast three-hybrid, RNA affinity pull-down from HeLa extracts, in vitro RNA-binding assay","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo yeast three-hybrid plus biochemical pull-down, single lab","pmids":["12466525"],"is_preprint":false},{"year":2004,"finding":"Omi/HtrA2 serine protease cleaves HAX-1 both in vitro and in vivo; HAX-1 degradation occurs early in apoptosis while Omi is still mitochondria-confined, suggesting Omi has a pro-apoptotic function within mitochondria by removing the anti-apoptotic HAX-1 protein. Cleavage is prevented by Omi-specific inhibitors and absent in cells with proteolytically inactive Omi.","method":"In vitro cleavage assay, cell-based apoptosis induction with specific Omi inhibitors, cell line with mutant Omi","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted cleavage assay with genetic and pharmacological validation","pmids":["15371414"],"is_preprint":false},{"year":2004,"finding":"HAX-1 was identified as a binding partner of BSEP, MDR1, and MDR2 ABC transporters; HAX-1 depletion by RNAi increased BSEP levels in the apical membrane of MDCK cells by 71% by enhancing retention without affecting translation or post-translational modification, suggesting HAX-1 participates in internalization of BSEP from the apical membrane.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, RNAi, pulse-chase","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods plus functional RNAi phenotype","pmids":["15159385"],"is_preprint":false},{"year":2004,"finding":"Gα13 physically interacts with HAX-1 (a cortactin-interacting protein); this interaction is required for Gα13-stimulated cell migration. HAX-1 expression reduces actin stress fibers and focal adhesion complexes, attenuates Gα13-stimulated RhoA activity while potentiating Rac activity, and participates in a quaternary complex with Gα13, Rac, and cortactin. HAX-1 siRNA knockdown drastically reduces Gα13-mediated cell migration.","method":"Co-immunoprecipitation, RhoA/Rac activity assays, siRNA knockdown, cell migration assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including Co-IP, activity assays, and siRNA with defined phenotypic readout","pmids":["15339924"],"is_preprint":false},{"year":2005,"finding":"HIV-1 Vpr physically associates with HAX-1; overexpression of Vpr dislocates HAX-1 from its normal mitochondrial residence, causing mitochondrial instability and cell death. Conversely, HAX-1 overexpression suppresses Vpr's pro-apoptotic activity.","method":"Co-immunoprecipitation, immunofluorescence localization, overexpression/rescue experiments","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional rescue, single lab","pmids":["16227293"],"is_preprint":false},{"year":2006,"finding":"HAX-1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells; loss-of-function HAX1 mutations cause autosomal recessive severe congenital neutropenia (Kostmann disease) with increased apoptosis in myeloid cells.","method":"Positional cloning, mitochondrial membrane potential assays in patient cells","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with defined mitochondrial and cellular phenotype, replicated across multiple pedigrees","pmids":["17187068"],"is_preprint":false},{"year":2006,"finding":"HAX-1 interacts with caspase-9 through yeast two-hybrid; recombinant HAX-1 inhibits caspase-9 processing in a dose-dependent manner in a cell-free caspase activation assay. HAX-1 overexpression protects adult cardiac myocytes from apoptosis; HAX-1 siRNA knockdown causes significant cell death. On apoptotic stimulation, caspase-9 translocates to mitochondria and co-localizes with HAX-1.","method":"Yeast two-hybrid, cell-free caspase activation assay, siRNA knockdown, immunofluorescence","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted caspase assay with mutagenesis, confirmed by cellular loss-of-function","pmids":["16857965"],"is_preprint":false},{"year":2006,"finding":"HAX-1 interacts with phospholamban (PLN); minimal binding regions mapped to amino acids 203-245 of HAX-1 and residues 16-22 of PLN, confirmed by GST pull-down and surface plasmon resonance (Kd ~1 µM). Phosphorylation of PLN by PKA reduced HAX-1 binding; elevated Ca2+ diminished the interaction. Upon PLN co-expression, HAX-1 redistributes from mitochondria to ER, and PLN enhances HAX-1's anti-apoptotic protection from hypoxia/reoxygenation.","method":"Yeast two-hybrid, GST pull-down, surface plasmon resonance, subcellular localization by transfection, apoptosis assay","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 — SPR binding kinetics plus domain mapping and functional assay","pmids":["17241641"],"is_preprint":false},{"year":2007,"finding":"HAX-1 binds to a hairpin structure in the 3'UTR of DNA polymerase beta mRNA in vitro; this interaction requires the intact hairpin motif. HAX-1 binds as a dimer; HAX-1 is present in nuclear matrix fractions in addition to mitochondria, suggesting a role in post-transcriptional regulation.","method":"RNA-protein binding assay (gel shift, UV-crosslinking), luciferase reporter system, biochemical fractionation, dimerization analysis","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding with mutagenesis plus reporter assay, single lab","pmids":["17704138"],"is_preprint":false},{"year":2008,"finding":"HAX-1 is required for Parl-mediated processing of HtrA2 to its active form in mitochondria: Hax1 interacts with both the mitochondrial rhomboid protease Parl and HtrA2, presenting HtrA2 to Parl for proteolytic processing. Processed HtrA2 in the intermembrane space prevents accumulation of activated Bax at the outer mitochondrial membrane. Loss of Hax1 in mouse lymphocytes and neurons leads to increased apoptosis.","method":"Genetic mouse knockout, biochemical interaction studies, mitochondrial processing assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — genetic model with biochemical mechanism, high-impact publication","pmids":["18288109"],"is_preprint":false},{"year":2008,"finding":"HAX-1 isoforms show genotype-phenotype correlation in congenital neutropenia: mutations affecting only transcript variant 1 cause neutropenia alone, while mutations affecting both transcript variants cause neutropenia plus neurological symptoms (epilepsy, developmental delay), reflecting differential expression of variant 2 in brain tissue.","method":"Molecular screening, RT-PCR of isoform expression in tissues, clinical phenotype analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — molecular and clinical phenotype correlation replicated in multiple patients","pmids":["18337561"],"is_preprint":false},{"year":2008,"finding":"HAX-1 binds to SERCA2 at amino acid residues 575-594 of SERCA2's nucleotide binding domain, interacting with the C-terminal domain (aa 203-245) of HAX-1. Triple transfection with PLN causes massive HAX-1 redistribution from mitochondria to ER where it co-distributes with PLN and SERCA2. SERCA2 overexpression abolishes HAX-1's protective effects on cell survival; HAX-1 overexpression down-regulates SERCA2 protein levels and reduces ER Ca2+ stores.","method":"Co-immunoprecipitation, deletion mapping, subcellular localization by transfection, cell survival assay, Ca2+ measurements","journal":"Molecular Biology of the Cell","confidence":"High","confidence_rationale":"Tier 2 — deletion mapping plus multiple functional assays in one study","pmids":["18971376"],"is_preprint":false},{"year":2008,"finding":"HAX-1 interacts with HIV-1 Rev and inhibits Rev/RRE-mediated gene expression by preventing Rev from binding to RRE RNA in vitro, and by relocating Rev from the nucleus to the cytoplasm when co-expressed.","method":"Co-immunoprecipitation, in vitro RNA binding assay, immunofluorescence, reporter gene assay","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro RNA-binding assay plus cellular localization and reporter assays","pmids":["17929250"],"is_preprint":false},{"year":2009,"finding":"HAX-1 overexpression reduces SERCA2 pump activity in cardiomyocytes and in vivo, depressing calcium kinetics and contractility. HAX-1 promotes formation of phospholamban monomers (the active/inhibitory units of the Ca pump). The inhibitory effects of HAX-1 are abolished upon PLN phosphorylation, and PLN ablation rescues HAX-1 inhibition of contractility in vivo.","method":"Transgenic mouse overexpression, cardiomyocyte Ca2+ measurements, contractility assays, PLN ablation genetic epistasis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic epistasis with PLN knockout plus multiple physiological readouts","pmids":["19920172"],"is_preprint":false},{"year":2009,"finding":"Hax-1 lacks bona fide Bcl-2 homology modules based on sequence analysis and secondary structure prediction, and in vivo the two proteins (Hax1 and PARL) are confined to distinct cellular compartments; their reported interaction is concluded to be an in vitro artifact, challenging the Hax1-PARL mechanistic model.","method":"Sequence/structure analysis, subcellular fractionation, in vitro interaction control experiments","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical fractionation plus bioinformatic analysis, contradicts prior model","pmids":["19680265"],"is_preprint":false},{"year":2010,"finding":"Granzyme B inserts into a proteinase K-resistant mitochondrial compartment and cleaves Hax-1 into an N-terminal fragment (retained at mitochondria) and a C-terminal fragment (released to cytosol). The N-terminal Hax-1 fragment acts as a dominant negative, mediating mitochondrial depolarization in a cyclophilin-D-dependent manner. Overexpression of wild-type or uncleavable mutant Hax-1 protects mitochondria from GrB-mediated depolarization.","method":"In vitro cleavage assay, mitochondrial import/fractionation, uncleavable mutant overexpression, mitochondrial membrane potential assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro cleavage reconstitution with mutant validation and defined mitochondrial functional readout","pmids":["20388708"],"is_preprint":false},{"year":2010,"finding":"HAX-1 interacts with XIAP at its BIR2 and BIR3 domains, while XIAP binds the C-terminal domain of HAX-1; HAX-1 suppresses polyubiquitination of XIAP, stabilizing it against proteasomal degradation, thereby inhibiting apoptosis.","method":"Immunoprecipitation, 2D gel electrophoresis proteomics, GST pull-down, surface plasmon resonance, ubiquitination assay","journal":"Biochemical and Biophysical Research Communications","confidence":"High","confidence_rationale":"Tier 1–2 — SPR binding kinetics plus biochemical domain mapping and functional ubiquitination assay","pmids":["20171186"],"is_preprint":false},{"year":2011,"finding":"Hax1 is a negative regulator of integrin-mediated adhesion and chemotaxis in neutrophils: Hax1 depletion impairs uropod detachment and directed migration, increases integrin-mediated adhesion, and reduces RhoA activity. RhoA depletion phenocopies Hax1 loss; RhoA activation rescues adhesion of Hax1-deficient neutrophils, placing Hax1 upstream of RhoA in the regulation of neutrophil migration.","method":"RNAi knockdown in PLB-985 cells, microfluidics, RhoA activity assays, rescue by constitutively active RhoA","journal":"Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (RhoA rescue) plus multiple functional readouts","pmids":["21518791"],"is_preprint":false},{"year":2012,"finding":"HAX-1 interacts with the influenza A virus PA polymerase subunit (specifically at PA's nuclear localization signal domain) and impedes PA nuclear translocation; HAX-1 knockdown increases nuclear PA accumulation and viral polymerase activity, whereas reexpression of HAX-1 reverses this, defining HAX-1 as a host restriction factor for influenza A.","method":"GST pull-down, co-immunoprecipitation, nuclear/cytoplasmic fractionation, HAX-1 knockdown and rescue, viral polymerase minigenome assay","journal":"Journal of Virology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, domain mapping, and functional knockdown/rescue with defined molecular mechanism","pmids":["23055567"],"is_preprint":false},{"year":2012,"finding":"HAX1 is required for G-CSF-triggered phosphorylation of HCLS1/HS1, which transports LEF-1 into the nucleus upon G-CSF stimulation; HAX1 mutations in congenital neutropenia patients cause defective HCLS1 phosphorylation and reduced LEF-1 autoregulation, impairing granulopoiesis.","method":"Phosphorylation assays, nuclear transport assays, patient cell studies, HCLS1-deficient mouse model","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including genetic models and patient cells, high-impact journal","pmids":["23001182"],"is_preprint":false},{"year":2012,"finding":"HAX-1 is a nucleocytoplasmic shuttling protein dependent on exportin-1 (XPO1/CRM1) for nuclear export; two nuclear export signals were identified by systematic mutagenesis. HAX-1 nuclear accumulation occurs after leptomycin B treatment or specific cellular stress. HAX-1 co-localizes with P-body markers and its status influences DNA polymerase β mRNA levels.","method":"Leptomycin B treatment, systematic mutagenesis of NES sequences, immunofluorescence, P-body co-localization","journal":"FEBS Journal","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis plus pharmacological inhibition, replicated across multiple approaches","pmids":["23164465"],"is_preprint":false},{"year":2012,"finding":"Hax-1 is rapidly degraded by the proteasome via K48-linked ubiquitin chains dependent on its PEST sequence; a deletion mutant lacking the PEST sequence is more resistant to proteasomal degradation and provides greater protection against apoptosis than wild-type Hax-1.","method":"Ubiquitination assay, proteasome inhibitor treatment, deletion mutagenesis, apoptosis assay","journal":"BMC Cell Biology","confidence":"High","confidence_rationale":"Tier 1 — deletion mutagenesis with direct biochemical validation of ubiquitination and functional consequence","pmids":["22827267"],"is_preprint":false},{"year":2012,"finding":"HAX-1 overexpression improves contractile recovery after cardiac ischemia/reperfusion and inhibits the IRE-1 ER stress signaling pathway (including caspase-12 and CHOP) through its binding to the N-terminal fragment of Hsp90; HAX-1 sequesters Hsp90 from IRE-1 to the PLN-SERCA complex.","method":"Cardiac-specific transgenic overexpression, Hsp90 co-immunoprecipitation, IRE-1 activity assays, Hsp90 inhibitor pharmacology","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of novel binding partner plus pharmacological validation and in vivo cardiac model","pmids":["22982986"],"is_preprint":false},{"year":2013,"finding":"Hax-1 proteins form homotypic and heterotypic dimers; variant 1 is anti-apoptotic while variant 2 (rat) / variant 4 (human) is pro-apoptotic. Co-expression of v1 and v2 neutralizes both activities by modulating cytochrome c release. Dimerization affinities range from ~3.8 nM for v1 homodimers to ~97 nM for v1/v2 heterodimers; minimal binding region spans aa 97-278.","method":"Surface plasmon resonance, cytochrome c release assay, overexpression of individual isoforms, deletion mapping","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — SPR binding kinetics plus functional assays with multiple isoforms","pmids":["24347163"],"is_preprint":false},{"year":2013,"finding":"Hax-1 was identified as a binding partner of two-pore channels TPC1 and TPC2 using yeast two-hybrid screen, with biochemical confirmation; the interaction may represent a mechanism by which endolysosomal ion channels are regulated.","method":"Yeast two-hybrid, biochemical validation (pulldown/Co-IP)","journal":"FEBS Letters","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP confirmation, minimal functional follow-up","pmids":["24188827"],"is_preprint":false},{"year":2014,"finding":"FBXO25 is the substrate-recognition subunit of SCF(FBXO25) ubiquitin ligase that targets HAX-1 for proteasomal degradation after apoptotic stress; PRKCD initiates this by phosphorylating both FBXO25 and HAX-1, directing nuclear FBXO25 to mitochondrial HAX-1. HAX-1 phosphodegron mutations prevent degradation and inhibit apoptosis; FBXO25 loss accelerates lymphomagenesis.","method":"Unbiased substrate screen, co-immunoprecipitation, ubiquitination assay, phosphorylation assay, mouse lymphoma model, xenotransplant","journal":"Nature Medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, in vivo mouse models, and patient mutation validation","pmids":["25419709"],"is_preprint":false},{"year":2014,"finding":"Hax-1 is required for Rac1-cortactin interaction in ovarian cancer cell migration; Hax-1 interacts with cortactin via domains aa 1-56 and aa 113-168, and with Rac1 via domains aa 57-112 and aa 169-224. Expression of competitive inhibitor domains reduces Rac1-cortactin colocalization and LPA-stimulated migration.","method":"Co-immunoprecipitation, domain mapping, siRNA knockdown, competitive inhibitor domain expression, migration assays","journal":"Genes & Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — domain mapping with competitive inhibitor approach and functional assay","pmids":["25053987"],"is_preprint":false},{"year":2015,"finding":"HAX-1 regulates cyclophilin-D protein levels and mitochondrial permeability transition pore (mPTP) activation: HAX-1 overexpression promotes cyclophilin-D ubiquitination and proteasomal degradation by interfering with cyclophilin-D binding to Hsp90 in mitochondria, thereby protecting against mPTP-mediated cell death.","method":"Cardiac-specific overexpression/heterozygous deficiency models, ubiquitination assay, proteasome inhibitor treatment, cyclophilin-D KO genetic epistasis, Hsp90 co-immunoprecipitation","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (cyclophilin-D KO rescue) plus biochemical ubiquitination and Co-IP data","pmids":["26553996"],"is_preprint":false},{"year":2015,"finding":"HAX-1 interacts with EB2 (microtubule end-binding protein 2) as identified by quantitative proteomics; knockdown of either HAX1 or EB2 stabilizes focal adhesions and impairs epidermal cell migration in vitro and in vivo, and this motility requires their interaction.","method":"Quantitative proteomics, co-immunoprecipitation, RNAi knockdown, in vitro and in vivo migration assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — proteomic identification with Co-IP confirmation and in vivo functional validation","pmids":["26527684"],"is_preprint":false},{"year":2016,"finding":"Kv3.3 channels recruit Arp2/3 to the plasma membrane via binding of Kv3.3's cytoplasmic C terminus to Hax-1, forming a cortical actin network resistant to cytochalasin D. These actin structures prevent rapid N-type channel inactivation. A human Kv3.3 disease mutation binds Hax-1 but cannot recruit Arp2/3, resulting in deficient actin veils in neurons.","method":"Co-immunoprecipitation, actin imaging, cytochalasin D treatment, electrophysiology, stem cell-derived neurons with disease mutation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including electrophysiology, actin reconstitution, and disease mutant validation","pmids":["26997484"],"is_preprint":false},{"year":2017,"finding":"HAX-1 regulates SERCA2a oxidation and degradation through two mechanisms: (1) binding to NAPDH oxidase 4 (NOX4) to reduce ROS production at the SR compartment, thereby reducing SERCA2a oxidation and proteolysis; (2) HAX-1 ablation increases NOX4-dependent ROS. Inducible cardiac-specific HAX-1 knockout impairs contractile recovery and increases infarct size after ischemia/reperfusion.","method":"Inducible cardiac-specific knockout, ROS measurements, SR microsome fractionation, NOX4 co-immunoprecipitation, apocynin pharmacology","journal":"Journal of Molecular and Cellular Cardiology","confidence":"High","confidence_rationale":"Tier 2 — inducible genetic model with mechanistic Co-IP and pharmacological validation","pmids":["29169992"],"is_preprint":false},{"year":2017,"finding":"Endogenous HAX-1 mediates approximately 50% of PLN's inhibitory activity on SERCA2a in the heart; cardiac-specific inducible HAX-1 ablation increases calcium affinity of SERCA2a and reduces PLN-SERCA2a binding without changing protein expression levels of SERCA2a, PLN, or ryanodine receptor.","method":"Inducible cardiac-specific knockout, calcium kinetics measurements, PLN-SERCA2a co-immunoprecipitation, isoproterenol stimulation, PLN-null genetic comparison","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — inducible genetic model with multiple calcium and contractility readouts, genetic epistasis with PLN null","pmids":["29150445"],"is_preprint":false},{"year":2019,"finding":"HAX-1 collectively regulates actomyosin contractility through RhoA and septin signaling: HAX-1 knockdown affects cell-cell junctions, substrate adhesion, and epithelial layer integrity. HAX-1 impacts collective but not single-cell migration.","method":"HAX-1 siRNA knockdown, RhoA activity assays, adhesion assays, collective migration assay","journal":"Molecular Biology of the Cell","confidence":"Medium","confidence_rationale":"Tier 2 — defined molecular pathway (RhoA/septin) with functional cellular readouts, single lab","pmids":["31644363"],"is_preprint":false},{"year":2020,"finding":"HAX-1 interacts with inositol 1,4,5-trisphosphate receptor-1 (InsP3R1) in the liver; hepatic HAX-1 ablation reduces InsP3R1 levels, improving ER-mitochondria calcium homeostasis, activating pyruvate dehydrogenase, and increasing mitochondrial utilization of glucose and fatty acids. HAX-1 ablation also increases bile salt exporter protein (BSEP) levels to promote enterohepatic bile acid recirculation.","method":"Liver-specific knockout, InsP3R1 co-immunoprecipitation, mitochondrial respiration assays, calcium homeostasis measurements","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — organ-specific genetic model with Co-IP and mechanistic metabolic readouts","pmids":["32079675"],"is_preprint":false},{"year":2021,"finding":"Kv3.3 channels bind and stimulate TBK1 (TANK-binding kinase 1); TBK1 activity is required for Kv3.3 to bind its auxiliary subunit Hax-1, which prevents channel inactivation. Disease-causing Kv3.3 mutation overactivates TBK1, leading to Hax-1 accumulation in multivesicular bodies/lysosomes, loss of Hax-1, caspase activation, and cerebellar neuron death.","method":"Co-immunoprecipitation, TBK1 inhibition, MVB/lysosome trafficking assay, caspase activation, cell death assay","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing Kv3.3-TBK1-Hax-1 pathway with disease mutation validation","pmids":["33741962"],"is_preprint":false},{"year":2022,"finding":"HAX1 and CLPB control the balance of mitochondrial protein synthesis and persistence (mitochondrial proteostasis), as shown by SILAC proteomics. HAX1/CLPB deficiency decreases PRKD2 abundance and phosphorylation of HSP27 on serines 78 and 82, impairing neutrophil granulocyte differentiation. Cellular defects in HAX1-/- cells can be rescued by HSP27, defining a CLPB/HAX1/(PRKD2)/HSP27 axis.","method":"SILAC proteomics, genetic knockout, HSP27 rescue experiments, HSP27 phosphorylation assays","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 — SILAC proteomics with genetic rescue establishing a mechanistic axis","pmids":["35499078"],"is_preprint":false},{"year":2024,"finding":"EIF3H functions as a deubiquitinase for HAX-1, stabilizing it by antagonizing βTrCP-mediated ubiquitination; stabilized HAX-1 enhances the interaction between RAF1, MEK1, and ERK1, potentiating ERK1/2 phosphorylation and promoting colorectal cancer progression.","method":"Co-immunoprecipitation, ubiquitination assay, deubiquitinase assay, RAF1-MEK1-ERK1 interaction mapping, mouse orthotopic cancer model","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods with in vivo tumor model and mechanistic pathway elucidation","pmids":["38514606"],"is_preprint":false}],"current_model":"HAX1 is a ubiquitously expressed, predominantly mitochondrial (and ER-associated) anti-apoptotic adaptor protein that suppresses cell death by inhibiting caspase-9 processing, protecting mitochondrial membrane potential, promoting HtrA2 processing via PARL, stabilizing XIAP, and being degraded by Omi/HtrA2 and granzyme B; it regulates cardiac calcium cycling by forming a PLN–HAX1–SERCA2a inhibitory complex (mediating ~50% of PLN's inhibitory activity), controls mPTP opening through Hsp90-dependent cyclophilin-D ubiquitination, links G-protein (Gα13) and Kv3.3 channel signaling to the actin cytoskeleton via cortactin/Rac1/Arp2/3 and TBK1, shuttles between nucleus and cytoplasm via CRM1/XPO1 nuclear export signals to participate in mRNA surveillance at P-bodies, and is itself regulated by FBXO25/PRKCD-dependent ubiquitin-proteasomal degradation and EIF3H-mediated deubiquitination."},"narrative":{"teleology":[{"year":1997,"claim":"Identification of HAX-1 as a novel mitochondrial/ER-localized protein interacting with the Src-kinase substrate HS1 established its potential role as an intracellular adaptor linking kinase signaling to organelle function.","evidence":"Yeast two-hybrid, co-immunoprecipitation, confocal microscopy with deletion mapping in multiple cell lines","pmids":["9058808"],"confidence":"High","gaps":["No function beyond binding was established","Endogenous interaction stoichiometry unknown"]},{"year":2002,"claim":"HAX-1 was shown to homodimerize and function as a potent apoptosis inhibitor, while also binding the 3′UTR of vimentin mRNA, revealing dual roles as both a survival factor and an RNA-binding protein.","evidence":"Apoptosis assays with overexpression, yeast three-hybrid RNA screen, in vitro RNA binding with recombinant protein","pmids":["11752170","12466525"],"confidence":"Medium","gaps":["Physiological RNA targets not comprehensively mapped","Mechanism of anti-apoptotic activity undefined"]},{"year":2004,"claim":"Two mechanistic arms of HAX-1 function were established: Omi/HtrA2 cleaves HAX-1 as a pro-apoptotic mechanism within mitochondria, and HAX-1 mediates Gα13-stimulated cell migration by scaffolding a Gα13–Rac–cortactin complex while attenuating RhoA.","evidence":"In vitro cleavage with Omi inhibitors and catalytically inactive mutant; Co-IP of Gα13–HAX-1–cortactin with RhoA/Rac activity assays and siRNA migration phenotype","pmids":["15371414","15339924"],"confidence":"High","gaps":["Omi cleavage site in HAX-1 not mapped","Relationship between cytoskeletal and mitochondrial functions not addressed"]},{"year":2006,"claim":"HAX1 was established as essential for human neutrophil survival—loss-of-function mutations cause Kostmann disease (severe congenital neutropenia)—while mechanistically HAX-1 was shown to inhibit caspase-9 processing and interact with the PLN–SERCA2a calcium-handling axis in cardiomyocytes.","evidence":"Positional cloning across multiple pedigrees with mitochondrial membrane potential assays; cell-free caspase-9 activation assay; SPR-measured PLN binding (Kd ~1 μM) with domain mapping","pmids":["17187068","16857965","17241641"],"confidence":"High","gaps":["Whether neutropenia is purely apoptotic or also involves differentiation defects was unresolved","In vivo cardiac role not yet demonstrated"]},{"year":2008,"claim":"A mitochondrial anti-apoptotic pathway was delineated in which HAX-1 presents HtrA2 to the rhomboid protease PARL for processing, and isoform-genotype-phenotype correlations explained why some HAX1 mutations cause neurological disease in addition to neutropenia.","evidence":"Hax1 knockout mouse with biochemical mitochondrial processing assays; RT-PCR isoform expression mapping with clinical phenotyping across patients","pmids":["18288109","18337561"],"confidence":"High","gaps":["PARL–HAX-1 interaction was subsequently challenged as a potential in vitro artifact (PMID:19680265)","Neuronal-specific functions of variant 2 remain mechanistically undefined"]},{"year":2010,"claim":"Granzyme B was shown to cleave HAX-1 within mitochondria generating a dominant-negative N-terminal fragment that triggers cyclophilin-D-dependent depolarization, while HAX-1 was found to stabilize XIAP by suppressing its polyubiquitination—defining two independent anti-apoptotic mechanisms.","evidence":"In vitro cleavage reconstitution with uncleavable mutant; SPR-confirmed XIAP binding with ubiquitination assay","pmids":["20388708","20171186"],"confidence":"High","gaps":["Whether granzyme B cleavage of HAX-1 is rate-limiting for cytotoxic lymphocyte killing in vivo unknown","E3 ligase mediating XIAP ubiquitination antagonized by HAX-1 not identified"]},{"year":2012,"claim":"HAX-1 was shown to be a nucleocytoplasmic shuttling protein with CRM1-dependent nuclear export signals, co-localizing with P-bodies and influencing DNA polymerase β mRNA levels, while its own turnover is controlled by PEST-sequence-dependent K48-linked ubiquitination. Separately, HAX-1 was linked to G-CSF-stimulated HCLS1 phosphorylation and LEF-1 nuclear transport in granulopoiesis.","evidence":"Leptomycin B treatment with systematic NES mutagenesis; ubiquitination assays with PEST deletion mutants; patient cell studies with HCLS1-deficient mouse model","pmids":["23164465","22827267","23001182"],"confidence":"High","gaps":["Full spectrum of HAX-1-regulated mRNAs not identified","Whether P-body localization is functionally required for mRNA surveillance unclear"]},{"year":2014,"claim":"The E3 ligase SCF(FBXO25) was identified as targeting HAX-1 for degradation after PRKCD-dependent phosphorylation during apoptotic stress, establishing the regulated degradation pathway whose dysregulation accelerates lymphomagenesis. HAX-1 was also shown to bridge Rac1–cortactin interaction for cell migration via defined binding domains.","evidence":"Unbiased substrate screen, phosphodegron mutants, mouse lymphoma model; domain mapping with competitive inhibitor peptides and migration assays","pmids":["25419709","25053987"],"confidence":"High","gaps":["Whether FBXO25 is the sole E3 for HAX-1 degradation was unresolved (βTrCP later implicated)","Relative contributions of Rac vs RhoA arms in different cell types unclear"]},{"year":2015,"claim":"HAX-1 was found to regulate cyclophilin-D levels by disrupting its Hsp90-dependent stabilization, thereby controlling mPTP opening, and separately shown to interact with EB2 to regulate focal adhesion dynamics and epidermal migration.","evidence":"Cardiac overexpression/haploinsufficiency with cyclophilin-D KO epistasis; quantitative proteomics with in vivo migration validation","pmids":["26553996","26527684"],"confidence":"High","gaps":["Whether cyclophilin-D regulation operates in non-cardiac tissues unknown","EB2–HAX-1 mechanism of focal adhesion destabilization not fully resolved"]},{"year":2016,"claim":"HAX-1 was established as an auxiliary subunit of Kv3.3 channels that recruits Arp2/3 to the plasma membrane to build cortical actin networks, preventing N-type inactivation; a human disease mutation in Kv3.3 binds HAX-1 but fails to recruit Arp2/3, linking HAX-1 to channelopathy.","evidence":"Co-immunoprecipitation, actin imaging, electrophysiology, stem cell-derived neurons with disease mutation","pmids":["26997484"],"confidence":"High","gaps":["Structural basis of Kv3.3–HAX-1 interaction unresolved","Whether HAX-1 regulates other voltage-gated channels unknown"]},{"year":2017,"claim":"Inducible cardiac-specific HAX-1 ablation demonstrated that endogenous HAX-1 mediates ~50% of PLN's inhibitory effect on SERCA2a and protects SERCA2a from NOX4-dependent oxidative degradation, establishing HAX-1 as a central regulator of cardiac calcium cycling.","evidence":"Inducible cardiac-specific knockout with calcium kinetics, PLN-SERCA2a co-immunoprecipitation, ROS measurements, NOX4 co-immunoprecipitation","pmids":["29150445","29169992"],"confidence":"High","gaps":["Whether HAX-1 regulation of SERCA2a is relevant in non-cardiac muscle or other tissues unknown","Precise stoichiometry of PLN–HAX-1–SERCA2a ternary complex not determined"]},{"year":2021,"claim":"The Kv3.3–HAX-1 pathway was extended upstream to TBK1, which is required for Kv3.3 binding to HAX-1; disease-causing Kv3.3 mutations overactivate TBK1, routing HAX-1 to lysosomes for degradation and triggering caspase-dependent cerebellar neuron death.","evidence":"Co-immunoprecipitation, TBK1 inhibition, MVB/lysosome trafficking, caspase and cell death assays","pmids":["33741962"],"confidence":"High","gaps":["Whether TBK1 directly phosphorylates HAX-1 or acts indirectly is unknown","Relevance to non-Kv3.3-related neurodegenerative conditions not explored"]},{"year":2022,"claim":"SILAC proteomics revealed that HAX1 and CLPB co-regulate mitochondrial proteostasis, with HAX1 deficiency reducing PRKD2 abundance and HSP27 phosphorylation, impairing neutrophil differentiation—a defect rescued by HSP27 re-expression, establishing a non-apoptotic mechanism for Kostmann disease.","evidence":"SILAC proteomics in HAX1-knockout cells, HSP27 rescue experiments, phosphorylation assays","pmids":["35499078"],"confidence":"High","gaps":["Whether the CLPB/HAX1/HSP27 axis is relevant to non-hematopoietic tissues unknown","Direct vs indirect regulation of PRKD2 by HAX1 not resolved"]},{"year":2024,"claim":"EIF3H was identified as a deubiquitinase that stabilizes HAX-1 by antagonizing βTrCP-mediated ubiquitination; stabilized HAX-1 scaffolds RAF1–MEK1–ERK1 interactions to potentiate MAPK signaling and promote colorectal cancer progression, revealing HAX-1 as a signaling scaffold beyond its anti-apoptotic role.","evidence":"Deubiquitinase assay, Co-IP of RAF1–MEK1–ERK1, ubiquitination assays, mouse orthotopic cancer model","pmids":["38514606"],"confidence":"High","gaps":["Whether HAX-1's MAPK scaffolding function operates in normal physiology or only in cancer context unknown","βTrCP degron site on HAX-1 not precisely mapped"]},{"year":null,"claim":"No high-resolution structure of HAX-1 exists, and the structural basis for its multivalent interactions with diverse partners (PLN, SERCA2a, cortactin, Rac1, Kv3.3, caspase-9, XIAP, RAF1) remains undefined. The relative importance of HAX-1's anti-apoptotic versus cytoskeletal versus mRNA regulatory functions in neutrophil biology and disease pathogenesis is incompletely resolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure available","Comprehensive interactome under physiological conditions not established","Cell-type-specific functions of individual HAX-1 isoforms remain poorly characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,29,39]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,19,30]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,29,32]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,4,8,12,18]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,10,14]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[23]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[23]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[32]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,8,9,12,18,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,39]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,22,38]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[24,28,39]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[14,16,34]}],"complexes":["PLN-HAX1-SERCA2a","Gα13-HAX1-Rac1-cortactin","Kv3.3-TBK1-HAX1-Arp2/3"],"partners":["PLN","ATP2A2","CASP9","XIAP","HCLS1","FBXO25","KCNC3","EIF3H"],"other_free_text":[]},"mechanistic_narrative":"HAX1 is a multifunctional anti-apoptotic adaptor protein that integrates mitochondrial survival signaling, cytoskeletal regulation, and post-transcriptional mRNA control. At mitochondria, HAX1 preserves inner membrane potential by facilitating PARL-mediated processing of HtrA2, inhibiting caspase-9 processing, stabilizing XIAP against ubiquitin-dependent degradation, and promoting cyclophilin-D ubiquitination to suppress mitochondrial permeability transition pore opening [PMID:18288109, PMID:16857965, PMID:20171186, PMID:26553996]. In cardiomyocytes, HAX1 forms a ternary complex with phospholamban (PLN) and SERCA2a, mediating approximately 50% of PLN's inhibitory effect on SERCA2a calcium affinity; its levels are controlled by FBXO25/PRKCD-dependent and βTrCP-dependent ubiquitination, counterbalanced by EIF3H deubiquitination, with stabilized HAX1 also scaffolding RAF1–MEK1–ERK1 signaling [PMID:29150445, PMID:25419709, PMID:38514606]. Loss-of-function mutations cause autosomal recessive severe congenital neutropenia (Kostmann disease), with isoform-specific mutations additionally producing neurological deficits, and HAX1 deficiency impairs neutrophil differentiation through a CLPB/PRKD2/HSP27 proteostasis axis [PMID:17187068, PMID:18337561, PMID:35499078]."},"prefetch_data":{"uniprot":{"accession":"O00165","full_name":"HCLS1-associated protein X-1","aliases":["HS1-associating protein X-1","HAX-1","HS1-binding protein 1","HSP1BP-1"],"length_aa":279,"mass_kda":31.6,"function":"Recruits the Arp2/3 complex to the cell cortex and regulates reorganization of the cortical actin cytoskeleton via its interaction with KCNC3 and the Arp2/3 complex (PubMed:26997484). Slows down the rate of inactivation of KCNC3 channels (PubMed:26997484). Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O00165/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HAX1","classification":"Not Classified","n_dependent_lines":176,"n_total_lines":1208,"dependency_fraction":0.1456953642384106},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HAX1","total_profiled":1310},"omim":[{"mim_id":"619835","title":"3-@METHYLGLUTACONIC ACIDURIA, TYPE VIIA; MGCA7A","url":"https://www.omim.org/entry/619835"},{"mim_id":"618592","title":"RING FINGER PROTEIN 217; RNF217","url":"https://www.omim.org/entry/618592"},{"mim_id":"616254","title":"CASEINOLYTIC PEPTIDASE B; CLPB","url":"https://www.omim.org/entry/616254"},{"mim_id":"611675","title":"KIAA0513 GENE; KIAA0513","url":"https://www.omim.org/entry/611675"},{"mim_id":"610738","title":"NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3","url":"https://www.omim.org/entry/610738"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HAX1"},"hgnc":{"alias_symbol":["HS1BP1","HCLSBP1","HAX-1"],"prev_symbol":[]},"alphafold":{"accession":"O00165","domains":[{"cath_id":"-","chopping":"209-244","consensus_level":"medium","plddt":92.0356,"start":209,"end":244}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00165","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00165-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00165-F1-predicted_aligned_error_v6.png","plddt_mean":59.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HAX1","jax_strain_url":"https://www.jax.org/strain/search?query=HAX1"},"sequence":{"accession":"O00165","fasta_url":"https://rest.uniprot.org/uniprotkb/O00165.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00165/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00165"}},"corpus_meta":[{"pmid":"17187068","id":"PMC_17187068","title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17187068","citation_count":363,"is_preprint":false},{"pmid":"18288109","id":"PMC_18288109","title":"Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18288109","citation_count":217,"is_preprint":false},{"pmid":"9058808","id":"PMC_9058808","title":"HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9058808","citation_count":215,"is_preprint":false},{"pmid":"11752170","id":"PMC_11752170","title":"K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function.","date":"2002","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11752170","citation_count":164,"is_preprint":false},{"pmid":"10760273","id":"PMC_10760273","title":"The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10760273","citation_count":160,"is_preprint":false},{"pmid":"15371414","id":"PMC_15371414","title":"Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15371414","citation_count":152,"is_preprint":false},{"pmid":"19775295","id":"PMC_19775295","title":"Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.","date":"2009","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19775295","citation_count":129,"is_preprint":false},{"pmid":"15339924","id":"PMC_15339924","title":"Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15339924","citation_count":122,"is_preprint":false},{"pmid":"16857965","id":"PMC_16857965","title":"Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16857965","citation_count":121,"is_preprint":false},{"pmid":"19120359","id":"PMC_19120359","title":"Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19120359","citation_count":101,"is_preprint":false},{"pmid":"19524642","id":"PMC_19524642","title":"HAX-1: a multifunctional protein with emerging roles in human disease.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19524642","citation_count":99,"is_preprint":false},{"pmid":"18971376","id":"PMC_18971376","title":"The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18971376","citation_count":92,"is_preprint":false},{"pmid":"15159385","id":"PMC_15159385","title":"Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15159385","citation_count":92,"is_preprint":false},{"pmid":"18337561","id":"PMC_18337561","title":"Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18337561","citation_count":91,"is_preprint":false},{"pmid":"17241641","id":"PMC_17241641","title":"Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17241641","citation_count":88,"is_preprint":false},{"pmid":"23001182","id":"PMC_23001182","title":"Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.","date":"2012","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23001182","citation_count":72,"is_preprint":false},{"pmid":"18513342","id":"PMC_18513342","title":"Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations.","date":"2008","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18513342","citation_count":70,"is_preprint":false},{"pmid":"16227293","id":"PMC_16227293","title":"Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16227293","citation_count":69,"is_preprint":false},{"pmid":"12466525","id":"PMC_12466525","title":"The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12466525","citation_count":69,"is_preprint":false},{"pmid":"22982986","id":"PMC_22982986","title":"Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.","date":"2012","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/22982986","citation_count":68,"is_preprint":false},{"pmid":"27618431","id":"PMC_27618431","title":"MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27618431","citation_count":68,"is_preprint":false},{"pmid":"26553996","id":"PMC_26553996","title":"HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26553996","citation_count":65,"is_preprint":false},{"pmid":"20196840","id":"PMC_20196840","title":"HAX-1 overexpression, splicing and cellular localization in tumors.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20196840","citation_count":60,"is_preprint":false},{"pmid":"26997484","id":"PMC_26997484","title":"Kv3.3 Channels Bind Hax-1 and Arp2/3 to Assemble a Stable Local Actin Network that Regulates Channel Gating.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26997484","citation_count":60,"is_preprint":false},{"pmid":"25419709","id":"PMC_25419709","title":"Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.","date":"2014","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25419709","citation_count":53,"is_preprint":false},{"pmid":"19920172","id":"PMC_19920172","title":"The anti-apoptotic protein HAX-1 is a regulator of cardiac function.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19920172","citation_count":51,"is_preprint":false},{"pmid":"23975175","id":"PMC_23975175","title":"Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis.","date":"2013","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23975175","citation_count":48,"is_preprint":false},{"pmid":"23055567","id":"PMC_23055567","title":"Cellular protein HAX1 interacts with the influenza A virus PA polymerase subunit and impedes its nuclear translocation.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/23055567","citation_count":47,"is_preprint":false},{"pmid":"11413368","id":"PMC_11413368","title":"Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway.","date":"2001","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/11413368","citation_count":47,"is_preprint":false},{"pmid":"18611981","id":"PMC_18611981","title":"Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene.","date":"2008","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18611981","citation_count":46,"is_preprint":false},{"pmid":"12787133","id":"PMC_12787133","title":"HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis.","date":"2003","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12787133","citation_count":46,"is_preprint":false},{"pmid":"21302289","id":"PMC_21302289","title":"HAX-1: a family of apoptotic regulators in health and disease.","date":"2011","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21302289","citation_count":45,"is_preprint":false},{"pmid":"27880721","id":"PMC_27880721","title":"Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27880721","citation_count":44,"is_preprint":false},{"pmid":"26871467","id":"PMC_26871467","title":"Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26871467","citation_count":43,"is_preprint":false},{"pmid":"21518791","id":"PMC_21518791","title":"Hax1 regulates neutrophil adhesion and motility through RhoA.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21518791","citation_count":43,"is_preprint":false},{"pmid":"17704138","id":"PMC_17704138","title":"Hairpin structure within the 3'UTR of DNA polymerase beta mRNA acts as a post-transcriptional regulatory element and interacts with Hax-1.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17704138","citation_count":42,"is_preprint":false},{"pmid":"19680265","id":"PMC_19680265","title":"Hax1 lacks BH modules and is peripherally associated to heavy membranes: implications for Omi/HtrA2 and PARL activity in the regulation of mitochondrial stress and apoptosis.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19680265","citation_count":42,"is_preprint":false},{"pmid":"29434858","id":"PMC_29434858","title":"miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29434858","citation_count":40,"is_preprint":false},{"pmid":"20171186","id":"PMC_20171186","title":"Molecular interaction between HAX-1 and XIAP inhibits apoptosis.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20171186","citation_count":38,"is_preprint":false},{"pmid":"20388708","id":"PMC_20388708","title":"Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20388708","citation_count":38,"is_preprint":false},{"pmid":"35524442","id":"PMC_35524442","title":"Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation.","date":"2022","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/35524442","citation_count":37,"is_preprint":false},{"pmid":"11554782","id":"PMC_11554782","title":"Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein.","date":"2001","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/11554782","citation_count":37,"is_preprint":false},{"pmid":"35499078","id":"PMC_35499078","title":"HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35499078","citation_count":36,"is_preprint":false},{"pmid":"21391832","id":"PMC_21391832","title":"Hax-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease.","date":"2011","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/21391832","citation_count":35,"is_preprint":false},{"pmid":"23164465","id":"PMC_23164465","title":"HAX-1 is a nucleocytoplasmic shuttling protein with a possible role in mRNA processing.","date":"2012","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/23164465","citation_count":34,"is_preprint":false},{"pmid":"26323553","id":"PMC_26323553","title":"HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26323553","citation_count":31,"is_preprint":false},{"pmid":"29975932","id":"PMC_29975932","title":"miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29975932","citation_count":30,"is_preprint":false},{"pmid":"26299953","id":"PMC_26299953","title":"Protease Omi cleaving Hax-1 protein contributes to OGD/R-induced mitochondrial damage in neuroblastoma N2a cells and cerebral injury in MCAO mice.","date":"2015","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/26299953","citation_count":30,"is_preprint":false},{"pmid":"27943080","id":"PMC_27943080","title":"Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).","date":"2016","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27943080","citation_count":29,"is_preprint":false},{"pmid":"19605487","id":"PMC_19605487","title":"Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19605487","citation_count":29,"is_preprint":false},{"pmid":"18330843","id":"PMC_18330843","title":"Association of HAX1 deficiency with neurological disorder.","date":"2007","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/18330843","citation_count":29,"is_preprint":false},{"pmid":"19620402","id":"PMC_19620402","title":"Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19620402","citation_count":28,"is_preprint":false},{"pmid":"20631090","id":"PMC_20631090","title":"The classical swine fever virus N-terminal protease N(pro) binds to cellular HAX-1.","date":"2010","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/20631090","citation_count":28,"is_preprint":false},{"pmid":"22827267","id":"PMC_22827267","title":"Hax-1 is rapidly degraded by the proteasome dependent on its PEST sequence.","date":"2012","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22827267","citation_count":28,"is_preprint":false},{"pmid":"16516414","id":"PMC_16516414","title":"Identification and expression analysis of alternative splice variants of the rat Hax-1 gene.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16516414","citation_count":27,"is_preprint":false},{"pmid":"17929250","id":"PMC_17929250","title":"An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.","date":"2008","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17929250","citation_count":26,"is_preprint":false},{"pmid":"26527684","id":"PMC_26527684","title":"Regulation of Focal Adhesion Dynamics and Cell Motility by the EB2 and Hax1 Protein Complex.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26527684","citation_count":26,"is_preprint":false},{"pmid":"19913549","id":"PMC_19913549","title":"HAX-1: a multifaceted antiapoptotic protein localizing in the mitochondria and the sarcoplasmic reticulum of striated muscle cells.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19913549","citation_count":26,"is_preprint":false},{"pmid":"18055975","id":"PMC_18055975","title":"Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency.","date":"2007","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/18055975","citation_count":26,"is_preprint":false},{"pmid":"31570982","id":"PMC_31570982","title":"Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.","date":"2019","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31570982","citation_count":26,"is_preprint":false},{"pmid":"29169992","id":"PMC_29169992","title":"HAX-1 regulates SERCA2a oxidation and degradation.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/29169992","citation_count":25,"is_preprint":false},{"pmid":"27506941","id":"PMC_27506941","title":"KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27506941","citation_count":25,"is_preprint":false},{"pmid":"21108402","id":"PMC_21108402","title":"HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21108402","citation_count":25,"is_preprint":false},{"pmid":"38514606","id":"PMC_38514606","title":"The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38514606","citation_count":24,"is_preprint":false},{"pmid":"19254774","id":"PMC_19254774","title":"Induction of apoptosis by Hax-1 siRNA in melanoma cells.","date":"2009","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/19254774","citation_count":24,"is_preprint":false},{"pmid":"31047882","id":"PMC_31047882","title":"HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31047882","citation_count":24,"is_preprint":false},{"pmid":"20406461","id":"PMC_20406461","title":"Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton.","date":"2010","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20406461","citation_count":24,"is_preprint":false},{"pmid":"21567072","id":"PMC_21567072","title":"hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cells.","date":"2011","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21567072","citation_count":23,"is_preprint":false},{"pmid":"26062578","id":"PMC_26062578","title":"Expression of HAX-1 in colorectal cancer and its role in cancer cell growth.","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/26062578","citation_count":23,"is_preprint":false},{"pmid":"22451114","id":"PMC_22451114","title":"HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells.","date":"2012","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22451114","citation_count":22,"is_preprint":false},{"pmid":"27654581","id":"PMC_27654581","title":"Endoplasmic reticulum (ER) stress triggers Hax1-dependent mitochondrial apoptotic events in cardiac cells.","date":"2016","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/27654581","citation_count":22,"is_preprint":false},{"pmid":"33741962","id":"PMC_33741962","title":"Cerebellar Kv3.3 potassium channels activate TANK-binding kinase 1 to regulate trafficking of the cell survival protein Hax-1.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33741962","citation_count":22,"is_preprint":false},{"pmid":"16814492","id":"PMC_16814492","title":"Expression and tissue distribution of mouse Hax1.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16814492","citation_count":21,"is_preprint":false},{"pmid":"29563290","id":"PMC_29563290","title":"H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.","date":"2018","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/29563290","citation_count":21,"is_preprint":false},{"pmid":"24347163","id":"PMC_24347163","title":"Competition through dimerization between antiapoptotic and proapoptotic HS-1-associated protein X-1 (Hax-1).","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24347163","citation_count":21,"is_preprint":false},{"pmid":"24482108","id":"PMC_24482108","title":"Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations.","date":"2014","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24482108","citation_count":20,"is_preprint":false},{"pmid":"20865787","id":"PMC_20865787","title":"HAX1 deficiency: impact on lymphopoiesis and B-cell development.","date":"2010","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20865787","citation_count":20,"is_preprint":false},{"pmid":"24188827","id":"PMC_24188827","title":"Hax-1 identified as a two-pore channel (TPC)-binding protein.","date":"2013","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24188827","citation_count":20,"is_preprint":false},{"pmid":"31321910","id":"PMC_31321910","title":"Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.","date":"2019","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31321910","citation_count":20,"is_preprint":false},{"pmid":"25053987","id":"PMC_25053987","title":"Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration.","date":"2014","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25053987","citation_count":20,"is_preprint":false},{"pmid":"24057929","id":"PMC_24057929","title":"Expression of HAX-1 in human colorectal cancer and its clinical significance.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24057929","citation_count":20,"is_preprint":false},{"pmid":"19036076","id":"PMC_19036076","title":"Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19036076","citation_count":20,"is_preprint":false},{"pmid":"29311840","id":"PMC_29311840","title":"HAX-1 Protects Glioblastoma Cells from Apoptosis through the Akt1 Pathway.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29311840","citation_count":19,"is_preprint":false},{"pmid":"29296734","id":"PMC_29296734","title":"Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.","date":"2017","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29296734","citation_count":19,"is_preprint":false},{"pmid":"29150445","id":"PMC_29150445","title":"The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29150445","citation_count":19,"is_preprint":false},{"pmid":"26339377","id":"PMC_26339377","title":"HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26339377","citation_count":18,"is_preprint":false},{"pmid":"29576744","id":"PMC_29576744","title":"Critical Role of HAX-1 in Promoting Avian Influenza Virus Replication in Lung Epithelial Cells.","date":"2018","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29576744","citation_count":16,"is_preprint":false},{"pmid":"32926529","id":"PMC_32926529","title":"HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32926529","citation_count":16,"is_preprint":false},{"pmid":"19123440","id":"PMC_19123440","title":"Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency.","date":"2008","source":"Journal of investigational allergology & clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19123440","citation_count":16,"is_preprint":false},{"pmid":"32079675","id":"PMC_32079675","title":"Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32079675","citation_count":15,"is_preprint":false},{"pmid":"32104694","id":"PMC_32104694","title":"miR-654-5p Targets HAX-1 to Regulate the Malignancy Behaviors of Colorectal Cancer Cells.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/32104694","citation_count":15,"is_preprint":false},{"pmid":"20182745","id":"PMC_20182745","title":"A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations.","date":"2010","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20182745","citation_count":15,"is_preprint":false},{"pmid":"24910348","id":"PMC_24910348","title":"Exploring the anti-apoptotic role of HAX-1 versus BCL-XL in cytokine-dependent bone marrow-derived cells from mice.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24910348","citation_count":15,"is_preprint":false},{"pmid":"25554539","id":"PMC_25554539","title":"Clinical significance of HAX-1 expression in laryngeal carcinoma.","date":"2014","source":"Auris, nasus, larynx","url":"https://pubmed.ncbi.nlm.nih.gov/25554539","citation_count":14,"is_preprint":false},{"pmid":"22315598","id":"PMC_22315598","title":"HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor.","date":"2012","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22315598","citation_count":14,"is_preprint":false},{"pmid":"31644363","id":"PMC_31644363","title":"HAX1 impact on collective cell migration, cell adhesion, and cell shape is linked to the regulation of actomyosin contractility.","date":"2019","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/31644363","citation_count":14,"is_preprint":false},{"pmid":"21136158","id":"PMC_21136158","title":"Traumatic brain injury induces an up-regulation of Hs1-associated protein X-1 (Hax-1) in rat brain cortex.","date":"2010","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/21136158","citation_count":14,"is_preprint":false},{"pmid":"25289648","id":"PMC_25289648","title":"HAX-1: a novel p-body protein.","date":"2015","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25289648","citation_count":13,"is_preprint":false},{"pmid":"28681255","id":"PMC_28681255","title":"Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation.","date":"2017","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28681255","citation_count":13,"is_preprint":false},{"pmid":"32327498","id":"PMC_32327498","title":"A zebrafish model for HAX1-associated congenital neutropenia.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/32327498","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47765,"output_tokens":9506,"usd":0.142943},"stage2":{"model":"claude-opus-4-6","input_tokens":13387,"output_tokens":4260,"usd":0.260153},"total_usd":0.403096,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"HAX-1 was identified as a novel intracellular protein that directly associates with HS1 (a substrate of Src family tyrosine kinases); the association is mediated by the amino-terminal region of HS1 and the carboxyl-terminal half of HAX-1, confirmed by yeast two-hybrid, co-immunoprecipitation, and confocal colocalization. HAX-1 localizes mainly to mitochondria but also to endoplasmic reticulum and nuclear envelope.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation, confocal microscopy, deletion mutant analysis\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and deletion mapping in multiple cell lines, foundational paper\",\n      \"pmids\": [\"9058808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HAX-1 interacts with the polycystic kidney disease protein PKD2 (but not the closely related PKD2L), and associates with the F-actin-binding protein cortactin, linking PKD2 to the actin cytoskeleton. PKD2 and HAX-1 co-localize in cellular processes and lamellipodia.\",\n      \"method\": \"Yeast two-hybrid screen, immunofluorescence co-localization\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid with immunofluorescence confirmation, single lab\",\n      \"pmids\": [\"10760273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HAX-1 can form homodimers in vivo and functions as a potent inhibitor of apoptosis. The KSHV K15 protein interacts with HAX-1 in vitro and in vivo, and HAX-1 co-localizes with K15 in the endoplasmic reticulum and mitochondria.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, immunofluorescence, apoptosis assays\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and functional apoptosis assays, single lab\",\n      \"pmids\": [\"11752170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HAX-1 binds the 3' untranslated region of vimentin mRNA as part of protein complexes also containing eEF-1gamma; recombinant HAX-1 protein binds this RNA in vitro with apparent specificity for vimentin's 3'UTR, identifying HAX-1 as an RNA-binding protein potentially involved in mRNA localization or stability.\",\n      \"method\": \"Yeast three-hybrid, RNA affinity pull-down from HeLa extracts, in vitro RNA-binding assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo yeast three-hybrid plus biochemical pull-down, single lab\",\n      \"pmids\": [\"12466525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Omi/HtrA2 serine protease cleaves HAX-1 both in vitro and in vivo; HAX-1 degradation occurs early in apoptosis while Omi is still mitochondria-confined, suggesting Omi has a pro-apoptotic function within mitochondria by removing the anti-apoptotic HAX-1 protein. Cleavage is prevented by Omi-specific inhibitors and absent in cells with proteolytically inactive Omi.\",\n      \"method\": \"In vitro cleavage assay, cell-based apoptosis induction with specific Omi inhibitors, cell line with mutant Omi\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted cleavage assay with genetic and pharmacological validation\",\n      \"pmids\": [\"15371414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HAX-1 was identified as a binding partner of BSEP, MDR1, and MDR2 ABC transporters; HAX-1 depletion by RNAi increased BSEP levels in the apical membrane of MDCK cells by 71% by enhancing retention without affecting translation or post-translational modification, suggesting HAX-1 participates in internalization of BSEP from the apical membrane.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, RNAi, pulse-chase\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods plus functional RNAi phenotype\",\n      \"pmids\": [\"15159385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Gα13 physically interacts with HAX-1 (a cortactin-interacting protein); this interaction is required for Gα13-stimulated cell migration. HAX-1 expression reduces actin stress fibers and focal adhesion complexes, attenuates Gα13-stimulated RhoA activity while potentiating Rac activity, and participates in a quaternary complex with Gα13, Rac, and cortactin. HAX-1 siRNA knockdown drastically reduces Gα13-mediated cell migration.\",\n      \"method\": \"Co-immunoprecipitation, RhoA/Rac activity assays, siRNA knockdown, cell migration assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including Co-IP, activity assays, and siRNA with defined phenotypic readout\",\n      \"pmids\": [\"15339924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HIV-1 Vpr physically associates with HAX-1; overexpression of Vpr dislocates HAX-1 from its normal mitochondrial residence, causing mitochondrial instability and cell death. Conversely, HAX-1 overexpression suppresses Vpr's pro-apoptotic activity.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence localization, overexpression/rescue experiments\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional rescue, single lab\",\n      \"pmids\": [\"16227293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HAX-1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells; loss-of-function HAX1 mutations cause autosomal recessive severe congenital neutropenia (Kostmann disease) with increased apoptosis in myeloid cells.\",\n      \"method\": \"Positional cloning, mitochondrial membrane potential assays in patient cells\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined mitochondrial and cellular phenotype, replicated across multiple pedigrees\",\n      \"pmids\": [\"17187068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HAX-1 interacts with caspase-9 through yeast two-hybrid; recombinant HAX-1 inhibits caspase-9 processing in a dose-dependent manner in a cell-free caspase activation assay. HAX-1 overexpression protects adult cardiac myocytes from apoptosis; HAX-1 siRNA knockdown causes significant cell death. On apoptotic stimulation, caspase-9 translocates to mitochondria and co-localizes with HAX-1.\",\n      \"method\": \"Yeast two-hybrid, cell-free caspase activation assay, siRNA knockdown, immunofluorescence\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted caspase assay with mutagenesis, confirmed by cellular loss-of-function\",\n      \"pmids\": [\"16857965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HAX-1 interacts with phospholamban (PLN); minimal binding regions mapped to amino acids 203-245 of HAX-1 and residues 16-22 of PLN, confirmed by GST pull-down and surface plasmon resonance (Kd ~1 µM). Phosphorylation of PLN by PKA reduced HAX-1 binding; elevated Ca2+ diminished the interaction. Upon PLN co-expression, HAX-1 redistributes from mitochondria to ER, and PLN enhances HAX-1's anti-apoptotic protection from hypoxia/reoxygenation.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, surface plasmon resonance, subcellular localization by transfection, apoptosis assay\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — SPR binding kinetics plus domain mapping and functional assay\",\n      \"pmids\": [\"17241641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HAX-1 binds to a hairpin structure in the 3'UTR of DNA polymerase beta mRNA in vitro; this interaction requires the intact hairpin motif. HAX-1 binds as a dimer; HAX-1 is present in nuclear matrix fractions in addition to mitochondria, suggesting a role in post-transcriptional regulation.\",\n      \"method\": \"RNA-protein binding assay (gel shift, UV-crosslinking), luciferase reporter system, biochemical fractionation, dimerization analysis\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding with mutagenesis plus reporter assay, single lab\",\n      \"pmids\": [\"17704138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HAX-1 is required for Parl-mediated processing of HtrA2 to its active form in mitochondria: Hax1 interacts with both the mitochondrial rhomboid protease Parl and HtrA2, presenting HtrA2 to Parl for proteolytic processing. Processed HtrA2 in the intermembrane space prevents accumulation of activated Bax at the outer mitochondrial membrane. Loss of Hax1 in mouse lymphocytes and neurons leads to increased apoptosis.\",\n      \"method\": \"Genetic mouse knockout, biochemical interaction studies, mitochondrial processing assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic model with biochemical mechanism, high-impact publication\",\n      \"pmids\": [\"18288109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HAX-1 isoforms show genotype-phenotype correlation in congenital neutropenia: mutations affecting only transcript variant 1 cause neutropenia alone, while mutations affecting both transcript variants cause neutropenia plus neurological symptoms (epilepsy, developmental delay), reflecting differential expression of variant 2 in brain tissue.\",\n      \"method\": \"Molecular screening, RT-PCR of isoform expression in tissues, clinical phenotype analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular and clinical phenotype correlation replicated in multiple patients\",\n      \"pmids\": [\"18337561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HAX-1 binds to SERCA2 at amino acid residues 575-594 of SERCA2's nucleotide binding domain, interacting with the C-terminal domain (aa 203-245) of HAX-1. Triple transfection with PLN causes massive HAX-1 redistribution from mitochondria to ER where it co-distributes with PLN and SERCA2. SERCA2 overexpression abolishes HAX-1's protective effects on cell survival; HAX-1 overexpression down-regulates SERCA2 protein levels and reduces ER Ca2+ stores.\",\n      \"method\": \"Co-immunoprecipitation, deletion mapping, subcellular localization by transfection, cell survival assay, Ca2+ measurements\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — deletion mapping plus multiple functional assays in one study\",\n      \"pmids\": [\"18971376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HAX-1 interacts with HIV-1 Rev and inhibits Rev/RRE-mediated gene expression by preventing Rev from binding to RRE RNA in vitro, and by relocating Rev from the nucleus to the cytoplasm when co-expressed.\",\n      \"method\": \"Co-immunoprecipitation, in vitro RNA binding assay, immunofluorescence, reporter gene assay\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro RNA-binding assay plus cellular localization and reporter assays\",\n      \"pmids\": [\"17929250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HAX-1 overexpression reduces SERCA2 pump activity in cardiomyocytes and in vivo, depressing calcium kinetics and contractility. HAX-1 promotes formation of phospholamban monomers (the active/inhibitory units of the Ca pump). The inhibitory effects of HAX-1 are abolished upon PLN phosphorylation, and PLN ablation rescues HAX-1 inhibition of contractility in vivo.\",\n      \"method\": \"Transgenic mouse overexpression, cardiomyocyte Ca2+ measurements, contractility assays, PLN ablation genetic epistasis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis with PLN knockout plus multiple physiological readouts\",\n      \"pmids\": [\"19920172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hax-1 lacks bona fide Bcl-2 homology modules based on sequence analysis and secondary structure prediction, and in vivo the two proteins (Hax1 and PARL) are confined to distinct cellular compartments; their reported interaction is concluded to be an in vitro artifact, challenging the Hax1-PARL mechanistic model.\",\n      \"method\": \"Sequence/structure analysis, subcellular fractionation, in vitro interaction control experiments\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical fractionation plus bioinformatic analysis, contradicts prior model\",\n      \"pmids\": [\"19680265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Granzyme B inserts into a proteinase K-resistant mitochondrial compartment and cleaves Hax-1 into an N-terminal fragment (retained at mitochondria) and a C-terminal fragment (released to cytosol). The N-terminal Hax-1 fragment acts as a dominant negative, mediating mitochondrial depolarization in a cyclophilin-D-dependent manner. Overexpression of wild-type or uncleavable mutant Hax-1 protects mitochondria from GrB-mediated depolarization.\",\n      \"method\": \"In vitro cleavage assay, mitochondrial import/fractionation, uncleavable mutant overexpression, mitochondrial membrane potential assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro cleavage reconstitution with mutant validation and defined mitochondrial functional readout\",\n      \"pmids\": [\"20388708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HAX-1 interacts with XIAP at its BIR2 and BIR3 domains, while XIAP binds the C-terminal domain of HAX-1; HAX-1 suppresses polyubiquitination of XIAP, stabilizing it against proteasomal degradation, thereby inhibiting apoptosis.\",\n      \"method\": \"Immunoprecipitation, 2D gel electrophoresis proteomics, GST pull-down, surface plasmon resonance, ubiquitination assay\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — SPR binding kinetics plus biochemical domain mapping and functional ubiquitination assay\",\n      \"pmids\": [\"20171186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hax1 is a negative regulator of integrin-mediated adhesion and chemotaxis in neutrophils: Hax1 depletion impairs uropod detachment and directed migration, increases integrin-mediated adhesion, and reduces RhoA activity. RhoA depletion phenocopies Hax1 loss; RhoA activation rescues adhesion of Hax1-deficient neutrophils, placing Hax1 upstream of RhoA in the regulation of neutrophil migration.\",\n      \"method\": \"RNAi knockdown in PLB-985 cells, microfluidics, RhoA activity assays, rescue by constitutively active RhoA\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (RhoA rescue) plus multiple functional readouts\",\n      \"pmids\": [\"21518791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HAX-1 interacts with the influenza A virus PA polymerase subunit (specifically at PA's nuclear localization signal domain) and impedes PA nuclear translocation; HAX-1 knockdown increases nuclear PA accumulation and viral polymerase activity, whereas reexpression of HAX-1 reverses this, defining HAX-1 as a host restriction factor for influenza A.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, nuclear/cytoplasmic fractionation, HAX-1 knockdown and rescue, viral polymerase minigenome assay\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, domain mapping, and functional knockdown/rescue with defined molecular mechanism\",\n      \"pmids\": [\"23055567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HAX1 is required for G-CSF-triggered phosphorylation of HCLS1/HS1, which transports LEF-1 into the nucleus upon G-CSF stimulation; HAX1 mutations in congenital neutropenia patients cause defective HCLS1 phosphorylation and reduced LEF-1 autoregulation, impairing granulopoiesis.\",\n      \"method\": \"Phosphorylation assays, nuclear transport assays, patient cell studies, HCLS1-deficient mouse model\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including genetic models and patient cells, high-impact journal\",\n      \"pmids\": [\"23001182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HAX-1 is a nucleocytoplasmic shuttling protein dependent on exportin-1 (XPO1/CRM1) for nuclear export; two nuclear export signals were identified by systematic mutagenesis. HAX-1 nuclear accumulation occurs after leptomycin B treatment or specific cellular stress. HAX-1 co-localizes with P-body markers and its status influences DNA polymerase β mRNA levels.\",\n      \"method\": \"Leptomycin B treatment, systematic mutagenesis of NES sequences, immunofluorescence, P-body co-localization\",\n      \"journal\": \"FEBS Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis plus pharmacological inhibition, replicated across multiple approaches\",\n      \"pmids\": [\"23164465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hax-1 is rapidly degraded by the proteasome via K48-linked ubiquitin chains dependent on its PEST sequence; a deletion mutant lacking the PEST sequence is more resistant to proteasomal degradation and provides greater protection against apoptosis than wild-type Hax-1.\",\n      \"method\": \"Ubiquitination assay, proteasome inhibitor treatment, deletion mutagenesis, apoptosis assay\",\n      \"journal\": \"BMC Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — deletion mutagenesis with direct biochemical validation of ubiquitination and functional consequence\",\n      \"pmids\": [\"22827267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HAX-1 overexpression improves contractile recovery after cardiac ischemia/reperfusion and inhibits the IRE-1 ER stress signaling pathway (including caspase-12 and CHOP) through its binding to the N-terminal fragment of Hsp90; HAX-1 sequesters Hsp90 from IRE-1 to the PLN-SERCA complex.\",\n      \"method\": \"Cardiac-specific transgenic overexpression, Hsp90 co-immunoprecipitation, IRE-1 activity assays, Hsp90 inhibitor pharmacology\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of novel binding partner plus pharmacological validation and in vivo cardiac model\",\n      \"pmids\": [\"22982986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hax-1 proteins form homotypic and heterotypic dimers; variant 1 is anti-apoptotic while variant 2 (rat) / variant 4 (human) is pro-apoptotic. Co-expression of v1 and v2 neutralizes both activities by modulating cytochrome c release. Dimerization affinities range from ~3.8 nM for v1 homodimers to ~97 nM for v1/v2 heterodimers; minimal binding region spans aa 97-278.\",\n      \"method\": \"Surface plasmon resonance, cytochrome c release assay, overexpression of individual isoforms, deletion mapping\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — SPR binding kinetics plus functional assays with multiple isoforms\",\n      \"pmids\": [\"24347163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hax-1 was identified as a binding partner of two-pore channels TPC1 and TPC2 using yeast two-hybrid screen, with biochemical confirmation; the interaction may represent a mechanism by which endolysosomal ion channels are regulated.\",\n      \"method\": \"Yeast two-hybrid, biochemical validation (pulldown/Co-IP)\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP confirmation, minimal functional follow-up\",\n      \"pmids\": [\"24188827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FBXO25 is the substrate-recognition subunit of SCF(FBXO25) ubiquitin ligase that targets HAX-1 for proteasomal degradation after apoptotic stress; PRKCD initiates this by phosphorylating both FBXO25 and HAX-1, directing nuclear FBXO25 to mitochondrial HAX-1. HAX-1 phosphodegron mutations prevent degradation and inhibit apoptosis; FBXO25 loss accelerates lymphomagenesis.\",\n      \"method\": \"Unbiased substrate screen, co-immunoprecipitation, ubiquitination assay, phosphorylation assay, mouse lymphoma model, xenotransplant\",\n      \"journal\": \"Nature Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, in vivo mouse models, and patient mutation validation\",\n      \"pmids\": [\"25419709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hax-1 is required for Rac1-cortactin interaction in ovarian cancer cell migration; Hax-1 interacts with cortactin via domains aa 1-56 and aa 113-168, and with Rac1 via domains aa 57-112 and aa 169-224. Expression of competitive inhibitor domains reduces Rac1-cortactin colocalization and LPA-stimulated migration.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, siRNA knockdown, competitive inhibitor domain expression, migration assays\",\n      \"journal\": \"Genes & Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain mapping with competitive inhibitor approach and functional assay\",\n      \"pmids\": [\"25053987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HAX-1 regulates cyclophilin-D protein levels and mitochondrial permeability transition pore (mPTP) activation: HAX-1 overexpression promotes cyclophilin-D ubiquitination and proteasomal degradation by interfering with cyclophilin-D binding to Hsp90 in mitochondria, thereby protecting against mPTP-mediated cell death.\",\n      \"method\": \"Cardiac-specific overexpression/heterozygous deficiency models, ubiquitination assay, proteasome inhibitor treatment, cyclophilin-D KO genetic epistasis, Hsp90 co-immunoprecipitation\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (cyclophilin-D KO rescue) plus biochemical ubiquitination and Co-IP data\",\n      \"pmids\": [\"26553996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HAX-1 interacts with EB2 (microtubule end-binding protein 2) as identified by quantitative proteomics; knockdown of either HAX1 or EB2 stabilizes focal adhesions and impairs epidermal cell migration in vitro and in vivo, and this motility requires their interaction.\",\n      \"method\": \"Quantitative proteomics, co-immunoprecipitation, RNAi knockdown, in vitro and in vivo migration assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomic identification with Co-IP confirmation and in vivo functional validation\",\n      \"pmids\": [\"26527684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Kv3.3 channels recruit Arp2/3 to the plasma membrane via binding of Kv3.3's cytoplasmic C terminus to Hax-1, forming a cortical actin network resistant to cytochalasin D. These actin structures prevent rapid N-type channel inactivation. A human Kv3.3 disease mutation binds Hax-1 but cannot recruit Arp2/3, resulting in deficient actin veils in neurons.\",\n      \"method\": \"Co-immunoprecipitation, actin imaging, cytochalasin D treatment, electrophysiology, stem cell-derived neurons with disease mutation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including electrophysiology, actin reconstitution, and disease mutant validation\",\n      \"pmids\": [\"26997484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HAX-1 regulates SERCA2a oxidation and degradation through two mechanisms: (1) binding to NAPDH oxidase 4 (NOX4) to reduce ROS production at the SR compartment, thereby reducing SERCA2a oxidation and proteolysis; (2) HAX-1 ablation increases NOX4-dependent ROS. Inducible cardiac-specific HAX-1 knockout impairs contractile recovery and increases infarct size after ischemia/reperfusion.\",\n      \"method\": \"Inducible cardiac-specific knockout, ROS measurements, SR microsome fractionation, NOX4 co-immunoprecipitation, apocynin pharmacology\",\n      \"journal\": \"Journal of Molecular and Cellular Cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible genetic model with mechanistic Co-IP and pharmacological validation\",\n      \"pmids\": [\"29169992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Endogenous HAX-1 mediates approximately 50% of PLN's inhibitory activity on SERCA2a in the heart; cardiac-specific inducible HAX-1 ablation increases calcium affinity of SERCA2a and reduces PLN-SERCA2a binding without changing protein expression levels of SERCA2a, PLN, or ryanodine receptor.\",\n      \"method\": \"Inducible cardiac-specific knockout, calcium kinetics measurements, PLN-SERCA2a co-immunoprecipitation, isoproterenol stimulation, PLN-null genetic comparison\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible genetic model with multiple calcium and contractility readouts, genetic epistasis with PLN null\",\n      \"pmids\": [\"29150445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HAX-1 collectively regulates actomyosin contractility through RhoA and septin signaling: HAX-1 knockdown affects cell-cell junctions, substrate adhesion, and epithelial layer integrity. HAX-1 impacts collective but not single-cell migration.\",\n      \"method\": \"HAX-1 siRNA knockdown, RhoA activity assays, adhesion assays, collective migration assay\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined molecular pathway (RhoA/septin) with functional cellular readouts, single lab\",\n      \"pmids\": [\"31644363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HAX-1 interacts with inositol 1,4,5-trisphosphate receptor-1 (InsP3R1) in the liver; hepatic HAX-1 ablation reduces InsP3R1 levels, improving ER-mitochondria calcium homeostasis, activating pyruvate dehydrogenase, and increasing mitochondrial utilization of glucose and fatty acids. HAX-1 ablation also increases bile salt exporter protein (BSEP) levels to promote enterohepatic bile acid recirculation.\",\n      \"method\": \"Liver-specific knockout, InsP3R1 co-immunoprecipitation, mitochondrial respiration assays, calcium homeostasis measurements\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — organ-specific genetic model with Co-IP and mechanistic metabolic readouts\",\n      \"pmids\": [\"32079675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Kv3.3 channels bind and stimulate TBK1 (TANK-binding kinase 1); TBK1 activity is required for Kv3.3 to bind its auxiliary subunit Hax-1, which prevents channel inactivation. Disease-causing Kv3.3 mutation overactivates TBK1, leading to Hax-1 accumulation in multivesicular bodies/lysosomes, loss of Hax-1, caspase activation, and cerebellar neuron death.\",\n      \"method\": \"Co-immunoprecipitation, TBK1 inhibition, MVB/lysosome trafficking assay, caspase activation, cell death assay\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing Kv3.3-TBK1-Hax-1 pathway with disease mutation validation\",\n      \"pmids\": [\"33741962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HAX1 and CLPB control the balance of mitochondrial protein synthesis and persistence (mitochondrial proteostasis), as shown by SILAC proteomics. HAX1/CLPB deficiency decreases PRKD2 abundance and phosphorylation of HSP27 on serines 78 and 82, impairing neutrophil granulocyte differentiation. Cellular defects in HAX1-/- cells can be rescued by HSP27, defining a CLPB/HAX1/(PRKD2)/HSP27 axis.\",\n      \"method\": \"SILAC proteomics, genetic knockout, HSP27 rescue experiments, HSP27 phosphorylation assays\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — SILAC proteomics with genetic rescue establishing a mechanistic axis\",\n      \"pmids\": [\"35499078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EIF3H functions as a deubiquitinase for HAX-1, stabilizing it by antagonizing βTrCP-mediated ubiquitination; stabilized HAX-1 enhances the interaction between RAF1, MEK1, and ERK1, potentiating ERK1/2 phosphorylation and promoting colorectal cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, deubiquitinase assay, RAF1-MEK1-ERK1 interaction mapping, mouse orthotopic cancer model\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods with in vivo tumor model and mechanistic pathway elucidation\",\n      \"pmids\": [\"38514606\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HAX1 is a ubiquitously expressed, predominantly mitochondrial (and ER-associated) anti-apoptotic adaptor protein that suppresses cell death by inhibiting caspase-9 processing, protecting mitochondrial membrane potential, promoting HtrA2 processing via PARL, stabilizing XIAP, and being degraded by Omi/HtrA2 and granzyme B; it regulates cardiac calcium cycling by forming a PLN–HAX1–SERCA2a inhibitory complex (mediating ~50% of PLN's inhibitory activity), controls mPTP opening through Hsp90-dependent cyclophilin-D ubiquitination, links G-protein (Gα13) and Kv3.3 channel signaling to the actin cytoskeleton via cortactin/Rac1/Arp2/3 and TBK1, shuttles between nucleus and cytoplasm via CRM1/XPO1 nuclear export signals to participate in mRNA surveillance at P-bodies, and is itself regulated by FBXO25/PRKCD-dependent ubiquitin-proteasomal degradation and EIF3H-mediated deubiquitination.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HAX1 is a multifunctional anti-apoptotic adaptor protein that integrates mitochondrial survival signaling, cytoskeletal regulation, and post-transcriptional mRNA control. At mitochondria, HAX1 preserves inner membrane potential by facilitating PARL-mediated processing of HtrA2, inhibiting caspase-9 processing, stabilizing XIAP against ubiquitin-dependent degradation, and promoting cyclophilin-D ubiquitination to suppress mitochondrial permeability transition pore opening [PMID:18288109, PMID:16857965, PMID:20171186, PMID:26553996]. In cardiomyocytes, HAX1 forms a ternary complex with phospholamban (PLN) and SERCA2a, mediating approximately 50% of PLN's inhibitory effect on SERCA2a calcium affinity; its levels are controlled by FBXO25/PRKCD-dependent and βTrCP-dependent ubiquitination, counterbalanced by EIF3H deubiquitination, with stabilized HAX1 also scaffolding RAF1–MEK1–ERK1 signaling [PMID:29150445, PMID:25419709, PMID:38514606]. Loss-of-function mutations cause autosomal recessive severe congenital neutropenia (Kostmann disease), with isoform-specific mutations additionally producing neurological deficits, and HAX1 deficiency impairs neutrophil differentiation through a CLPB/PRKD2/HSP27 proteostasis axis [PMID:17187068, PMID:18337561, PMID:35499078].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of HAX-1 as a novel mitochondrial/ER-localized protein interacting with the Src-kinase substrate HS1 established its potential role as an intracellular adaptor linking kinase signaling to organelle function.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, confocal microscopy with deletion mapping in multiple cell lines\",\n      \"pmids\": [\"9058808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No function beyond binding was established\", \"Endogenous interaction stoichiometry unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"HAX-1 was shown to homodimerize and function as a potent apoptosis inhibitor, while also binding the 3′UTR of vimentin mRNA, revealing dual roles as both a survival factor and an RNA-binding protein.\",\n      \"evidence\": \"Apoptosis assays with overexpression, yeast three-hybrid RNA screen, in vitro RNA binding with recombinant protein\",\n      \"pmids\": [\"11752170\", \"12466525\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological RNA targets not comprehensively mapped\", \"Mechanism of anti-apoptotic activity undefined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Two mechanistic arms of HAX-1 function were established: Omi/HtrA2 cleaves HAX-1 as a pro-apoptotic mechanism within mitochondria, and HAX-1 mediates Gα13-stimulated cell migration by scaffolding a Gα13–Rac–cortactin complex while attenuating RhoA.\",\n      \"evidence\": \"In vitro cleavage with Omi inhibitors and catalytically inactive mutant; Co-IP of Gα13–HAX-1–cortactin with RhoA/Rac activity assays and siRNA migration phenotype\",\n      \"pmids\": [\"15371414\", \"15339924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Omi cleavage site in HAX-1 not mapped\", \"Relationship between cytoskeletal and mitochondrial functions not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"HAX1 was established as essential for human neutrophil survival—loss-of-function mutations cause Kostmann disease (severe congenital neutropenia)—while mechanistically HAX-1 was shown to inhibit caspase-9 processing and interact with the PLN–SERCA2a calcium-handling axis in cardiomyocytes.\",\n      \"evidence\": \"Positional cloning across multiple pedigrees with mitochondrial membrane potential assays; cell-free caspase-9 activation assay; SPR-measured PLN binding (Kd ~1 μM) with domain mapping\",\n      \"pmids\": [\"17187068\", \"16857965\", \"17241641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether neutropenia is purely apoptotic or also involves differentiation defects was unresolved\", \"In vivo cardiac role not yet demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A mitochondrial anti-apoptotic pathway was delineated in which HAX-1 presents HtrA2 to the rhomboid protease PARL for processing, and isoform-genotype-phenotype correlations explained why some HAX1 mutations cause neurological disease in addition to neutropenia.\",\n      \"evidence\": \"Hax1 knockout mouse with biochemical mitochondrial processing assays; RT-PCR isoform expression mapping with clinical phenotyping across patients\",\n      \"pmids\": [\"18288109\", \"18337561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PARL–HAX-1 interaction was subsequently challenged as a potential in vitro artifact (PMID:19680265)\", \"Neuronal-specific functions of variant 2 remain mechanistically undefined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Granzyme B was shown to cleave HAX-1 within mitochondria generating a dominant-negative N-terminal fragment that triggers cyclophilin-D-dependent depolarization, while HAX-1 was found to stabilize XIAP by suppressing its polyubiquitination—defining two independent anti-apoptotic mechanisms.\",\n      \"evidence\": \"In vitro cleavage reconstitution with uncleavable mutant; SPR-confirmed XIAP binding with ubiquitination assay\",\n      \"pmids\": [\"20388708\", \"20171186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether granzyme B cleavage of HAX-1 is rate-limiting for cytotoxic lymphocyte killing in vivo unknown\", \"E3 ligase mediating XIAP ubiquitination antagonized by HAX-1 not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"HAX-1 was shown to be a nucleocytoplasmic shuttling protein with CRM1-dependent nuclear export signals, co-localizing with P-bodies and influencing DNA polymerase β mRNA levels, while its own turnover is controlled by PEST-sequence-dependent K48-linked ubiquitination. Separately, HAX-1 was linked to G-CSF-stimulated HCLS1 phosphorylation and LEF-1 nuclear transport in granulopoiesis.\",\n      \"evidence\": \"Leptomycin B treatment with systematic NES mutagenesis; ubiquitination assays with PEST deletion mutants; patient cell studies with HCLS1-deficient mouse model\",\n      \"pmids\": [\"23164465\", \"22827267\", \"23001182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of HAX-1-regulated mRNAs not identified\", \"Whether P-body localization is functionally required for mRNA surveillance unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The E3 ligase SCF(FBXO25) was identified as targeting HAX-1 for degradation after PRKCD-dependent phosphorylation during apoptotic stress, establishing the regulated degradation pathway whose dysregulation accelerates lymphomagenesis. HAX-1 was also shown to bridge Rac1–cortactin interaction for cell migration via defined binding domains.\",\n      \"evidence\": \"Unbiased substrate screen, phosphodegron mutants, mouse lymphoma model; domain mapping with competitive inhibitor peptides and migration assays\",\n      \"pmids\": [\"25419709\", \"25053987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FBXO25 is the sole E3 for HAX-1 degradation was unresolved (βTrCP later implicated)\", \"Relative contributions of Rac vs RhoA arms in different cell types unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"HAX-1 was found to regulate cyclophilin-D levels by disrupting its Hsp90-dependent stabilization, thereby controlling mPTP opening, and separately shown to interact with EB2 to regulate focal adhesion dynamics and epidermal migration.\",\n      \"evidence\": \"Cardiac overexpression/haploinsufficiency with cyclophilin-D KO epistasis; quantitative proteomics with in vivo migration validation\",\n      \"pmids\": [\"26553996\", \"26527684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cyclophilin-D regulation operates in non-cardiac tissues unknown\", \"EB2–HAX-1 mechanism of focal adhesion destabilization not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"HAX-1 was established as an auxiliary subunit of Kv3.3 channels that recruits Arp2/3 to the plasma membrane to build cortical actin networks, preventing N-type inactivation; a human disease mutation in Kv3.3 binds HAX-1 but fails to recruit Arp2/3, linking HAX-1 to channelopathy.\",\n      \"evidence\": \"Co-immunoprecipitation, actin imaging, electrophysiology, stem cell-derived neurons with disease mutation\",\n      \"pmids\": [\"26997484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Kv3.3–HAX-1 interaction unresolved\", \"Whether HAX-1 regulates other voltage-gated channels unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Inducible cardiac-specific HAX-1 ablation demonstrated that endogenous HAX-1 mediates ~50% of PLN's inhibitory effect on SERCA2a and protects SERCA2a from NOX4-dependent oxidative degradation, establishing HAX-1 as a central regulator of cardiac calcium cycling.\",\n      \"evidence\": \"Inducible cardiac-specific knockout with calcium kinetics, PLN-SERCA2a co-immunoprecipitation, ROS measurements, NOX4 co-immunoprecipitation\",\n      \"pmids\": [\"29150445\", \"29169992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HAX-1 regulation of SERCA2a is relevant in non-cardiac muscle or other tissues unknown\", \"Precise stoichiometry of PLN–HAX-1–SERCA2a ternary complex not determined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The Kv3.3–HAX-1 pathway was extended upstream to TBK1, which is required for Kv3.3 binding to HAX-1; disease-causing Kv3.3 mutations overactivate TBK1, routing HAX-1 to lysosomes for degradation and triggering caspase-dependent cerebellar neuron death.\",\n      \"evidence\": \"Co-immunoprecipitation, TBK1 inhibition, MVB/lysosome trafficking, caspase and cell death assays\",\n      \"pmids\": [\"33741962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TBK1 directly phosphorylates HAX-1 or acts indirectly is unknown\", \"Relevance to non-Kv3.3-related neurodegenerative conditions not explored\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"SILAC proteomics revealed that HAX1 and CLPB co-regulate mitochondrial proteostasis, with HAX1 deficiency reducing PRKD2 abundance and HSP27 phosphorylation, impairing neutrophil differentiation—a defect rescued by HSP27 re-expression, establishing a non-apoptotic mechanism for Kostmann disease.\",\n      \"evidence\": \"SILAC proteomics in HAX1-knockout cells, HSP27 rescue experiments, phosphorylation assays\",\n      \"pmids\": [\"35499078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the CLPB/HAX1/HSP27 axis is relevant to non-hematopoietic tissues unknown\", \"Direct vs indirect regulation of PRKD2 by HAX1 not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"EIF3H was identified as a deubiquitinase that stabilizes HAX-1 by antagonizing βTrCP-mediated ubiquitination; stabilized HAX-1 scaffolds RAF1–MEK1–ERK1 interactions to potentiate MAPK signaling and promote colorectal cancer progression, revealing HAX-1 as a signaling scaffold beyond its anti-apoptotic role.\",\n      \"evidence\": \"Deubiquitinase assay, Co-IP of RAF1–MEK1–ERK1, ubiquitination assays, mouse orthotopic cancer model\",\n      \"pmids\": [\"38514606\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HAX-1's MAPK scaffolding function operates in normal physiology or only in cancer context unknown\", \"βTrCP degron site on HAX-1 not precisely mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No high-resolution structure of HAX-1 exists, and the structural basis for its multivalent interactions with diverse partners (PLN, SERCA2a, cortactin, Rac1, Kv3.3, caspase-9, XIAP, RAF1) remains undefined. The relative importance of HAX-1's anti-apoptotic versus cytoskeletal versus mRNA regulatory functions in neutrophil biology and disease pathogenesis is incompletely resolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Comprehensive interactome under physiological conditions not established\", \"Cell-type-specific functions of individual HAX-1 isoforms remain poorly characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 29, 39]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 19, 30]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 29, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 4, 8, 12, 18]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 10, 14]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 8, 9, 12, 18, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 39]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 22, 38]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [24, 28, 39]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [14, 16, 34]}\n    ],\n    \"complexes\": [\n      \"PLN-HAX1-SERCA2a\",\n      \"Gα13-HAX1-Rac1-cortactin\",\n      \"Kv3.3-TBK1-HAX1-Arp2/3\"\n    ],\n    \"partners\": [\n      \"PLN\",\n      \"ATP2A2\",\n      \"CASP9\",\n      \"XIAP\",\n      \"HCLS1\",\n      \"FBXO25\",\n      \"KCNC3\",\n      \"EIF3H\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}